CVRx, Inc. Cost of Revenue
CVRx, Inc. (CVRX) reported Cost of Revenue of $1.98 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement
us-gaap:CostOfRevenue · last filed 2026-08-06
- CVRx, Inc. cost of revenue for the quarter ending 2026-06-30 was $1.98M, a 7.39% decline year-over-year.
- CVRx, Inc. cost of revenue for the quarter ending 2026-03-31 was $1.89M, a 7.27% decline year-over-year.
- CVRx, Inc. cost of revenue for the quarter ending 2025-12-31 was $2.20M, a 14.47% decline year-over-year.
- CVRx, Inc. cost of revenue for the quarter ending 2025-09-30 was $1.94M, a 13.83% decline year-over-year.
- CVRx, Inc. cost of revenue for fiscal 2025 was $8.31M, a 0.28% decline from fiscal 2024.
- CVRx, Inc. cost of revenue for fiscal 2024 was $8.33M, a 33.22% increase from fiscal 2023.
- CVRx, Inc. cost of revenue for fiscal 2023 was $6.26M, a 25.15% increase from fiscal 2022.
- CVRx, Inc. cost of revenue for fiscal 2022 was $5.00M, a 37.34% increase from fiscal 2021.
| Period end | Cost of Revenue 3 month | Cost of Revenue 6 month | Cost of Revenue 9 month | Cost of Revenue 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.98M 10-Q · filed 2026-08-06 | $3.87M 10-Q · filed 2026-08-06 | $6.07M derived: sum of 3 quarters · filed 2026-08-06 | $8.01M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $1.89M 10-Q · filed 2026-05-12 | $4.09M derived: sum of 2 quarters · filed 2026-05-12 | $6.02M derived: sum of 3 quarters · filed 2026-05-12 | $8.16M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $2.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $4.14M derived: sum of 2 quarters · filed 2026-02-13 | $6.28M derived: sum of 3 quarters · filed 2026-08-06 | $8.31M 10-K · filed 2026-02-13 |
| 2025-09-30 | $1.94M 10-Q · filed 2025-11-06 | $4.08M derived: sum of 2 quarters · filed 2026-08-06 | $6.11M 10-Q · filed 2025-11-06 | $8.68M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $2.14M 10-Q · filed 2026-08-06 | $4.17M 10-Q · filed 2026-08-06 | $6.75M derived: sum of 3 quarters · filed 2026-08-06 | $8.99M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $2.04M 10-Q · filed 2026-05-12 | $4.61M derived: sum of 2 quarters · filed 2026-05-12 | $6.86M derived: sum of 3 quarters · filed 2026-05-12 | $8.76M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $2.57M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $4.82M derived: sum of 2 quarters · filed 2026-02-13 | $6.72M derived: sum of 3 quarters · filed 2026-02-13 | $8.33M 10-K · filed 2026-02-13 |
| 2024-09-30 | $2.25M 10-Q · filed 2025-11-06 | $4.15M derived: sum of 2 quarters · filed 2025-11-06 | $5.76M 10-Q · filed 2025-11-06 | $7.48M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $1.90M 10-Q · filed 2025-08-05 | $3.52M 10-Q · filed 2025-08-05 | $5.24M derived: sum of 3 quarters · filed 2025-08-05 | $6.93M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $1.61M 10-Q · filed 2025-05-09 | $3.33M derived: sum of 2 quarters · filed 2025-05-09 | $5.03M derived: sum of 3 quarters · filed 2025-05-09 | $6.54M derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | $1.72M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $3.41M derived: sum of 2 quarters · filed 2025-02-18 | $4.93M derived: sum of 3 quarters · filed 2025-02-18 | $6.26M 10-K · filed 2025-02-18 |
| 2023-09-30 | $1.69M 10-Q · filed 2024-11-01 | $3.21M derived: sum of 2 quarters · filed 2024-11-01 | $4.54M 10-Q · filed 2024-11-01 | $6.04M derived: sum of 4 quarters · filed 2024-11-01 |
| 2023-06-30 | $1.52M 10-Q · filed 2024-08-02 | $2.85M 10-Q · filed 2024-08-02 | $4.35M derived: sum of 3 quarters · filed 2024-08-02 | $5.69M derived: sum of 4 quarters · filed 2024-08-02 |
| 2023-03-31 | $1.33M 10-Q · filed 2024-05-10 | $2.84M derived: sum of 2 quarters · filed 2024-05-10 | $4.18M derived: sum of 3 quarters · filed 2024-05-10 | $5.38M derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $1.51M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-09 | $2.85M derived: sum of 2 quarters · filed 2024-02-09 | $4.05M derived: sum of 3 quarters · filed 2024-02-09 | $5.00M 10-K · filed 2024-02-09 |
| 2022-09-30 | $1.34M 10-Q · filed 2023-10-31 | $2.54M derived: sum of 2 quarters · filed 2023-10-31 | $3.49M 10-Q · filed 2023-10-31 | $4.47M derived: sum of 4 quarters · filed 2023-10-31 |
| 2022-06-30 | $1.20M 10-Q · filed 2023-08-03 | $2.15M 10-Q · filed 2023-08-03 | $3.13M derived: sum of 3 quarters · filed 2023-08-03 | $4.01M derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | $949.00K 10-Q · filed 2023-05-11 | $1.93M derived: sum of 2 quarters · filed 2023-05-11 | $2.81M derived: sum of 3 quarters · filed 2023-05-11 | $3.72M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $984.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | $1.86M derived: sum of 2 quarters · filed 2023-02-10 | $2.77M derived: sum of 3 quarters · filed 2023-02-10 | $3.64M 10-K · filed 2023-02-10 |
| 2021-09-30 | $876.00K 10-Q · filed 2022-11-04 | $1.79M derived: sum of 2 quarters · filed 2022-11-04 | $2.66M 10-Q · filed 2022-11-04 | $3.11M derived: sum of 4 quarters · filed 2022-11-04 |
| 2021-06-30 | $913.00K 10-Q · filed 2022-08-01 | $1.78M 10-Q · filed 2022-08-01 | $2.23M derived: sum of 3 quarters · filed 2022-08-01 | $2.44M derived: sum of 4 quarters · filed 2022-08-01 |
| 2021-03-31 | $867.00K 10-Q · filed 2022-05-02 | $1.32M derived: sum of 2 quarters · filed 2022-05-02 | $1.53M derived: sum of 3 quarters · filed 2022-05-02 | $1.88M derived: sum of 4 quarters · filed 2022-05-02 |
| 2020-12-31 | $451.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $663.00K derived: sum of 2 quarters · filed 2022-02-22 | $1.01M derived: sum of 3 quarters · filed 2022-02-22 | $1.44M 10-K · filed 2022-02-22 |
| 2020-09-30 | $212.00K 10-Q · filed 2021-11-08 | $557.00K derived: sum of 2 quarters · filed 2021-11-08 | $989.00K 10-Q · filed 2021-11-08 | |
| 2020-06-30 | $345.00K 10-Q · filed 2021-08-09 | $777.00K 10-Q · filed 2021-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |